Chemoinformaics analysis of N-octan-3-ylidenehydroxylamine
| Molecular Weight | 143.23 | nRot | 5 |
| Heavy Atom Molecular Weight | 126.094 | nRig | 1 |
| Exact Molecular Weight | 143.131 | nRing | 0 |
| Solubility: LogS | -1.911 | nHRing | 0 |
| Solubility: LogP | 2.481 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 26.5975 |
| nHD | 1 | BPOL | 17.0545 |
| QED | 0.273 |
| Synth | 2.571 |
| Natural Product Likeliness | 0.264 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.459 |
| MDCK | 0.0000282 |
| BBB | 0.997 |
| PPB | 0.9094 |
| VDSS | 1.293 |
| FU | 0.1611 |
| CYP1A2-inh | 0.753 |
| CYP1A2-sub | 0.404 |
| CYP2c19-inh | 0.417 |
| CYP2c19-sub | 0.382 |
| CYP2c9-inh | 0.167 |
| CYP2c9-sub | 0.816 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.259 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.232 |
| CL | 1.678 |
| T12 | 0.546 |
| hERG | 0.016 |
| Ames | 0.353 |
| ROA | 0.135 |
| SkinSen | 0.81 |
| Carcinogencity | 0.954 |
| EI | 0.973 |
| Respiratory | 0.472 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.938387 |